Correction to "Safety and Efficacy of Gadobutrol for Contrast-enhanced Magnetic Resonance Imaging of the Central Nervous System: Results from a Multicenter, Double-blind, Randomized, Comparator Study"
Magn Reson Insights
.
2015 Jul 21:8:23.
doi: 10.4137/MRI.S30060.
eCollection 2015.
Authors
Juan E Gutierrez
1
,
Martin Rosenberg
2
,
Jörg Seemann
3
,
Josy Breuer
4
,
Daniel Haverstock
2
,
Jacob Agris
2
,
Thomas Balzer
2
,
Nicoletta Anzalone
5
Affiliations
1
Neuroradiology Section, The University of Texas Health Science Center at San Antonio, TX, USA.
2
Bayer Healthcare Pharmaceuticals, Montville, NJ, USA.
3
Department of Neuroradiology, Werner-Forßmann Krankenhaus, Eberswalde, Germany.
4
Global Clinical Imaging Services, Bayer Pharma AG, Berlin, Germany.
5
Neuroradiology Department, Scientific Institute HSR Raffaele, Milan, Italy.
PMID:
26279622
PMCID:
PMC4512634
DOI:
10.4137/MRI.S30060
No abstract available
Publication types
Published Erratum